curcumin and Granulomatous-Disease--Chronic

curcumin has been researched along with Granulomatous-Disease--Chronic* in 1 studies

Other Studies

1 other study(ies) available for curcumin and Granulomatous-Disease--Chronic

Article	Year
Targeted Delivery of Curcumin Rescues Endoplasmic Reticulum-Retained Mutant NOX2 Protein and Avoids Leukocyte Apoptosis. Journal of immunology (Baltimore, Md. : 1950), 2019, 06-15, Volume: 202, Issue:12 Chronic granulomatous disease (CGD) is a primary immunodeficiency disease caused by defects in the leukocyte NADP oxidase. We previously reported that sarcoplasmic/endoplasmic reticulum calcium pump (SERCA) inhibitors could be used to rescue mutant H338Y-gp91phox protein of a particular type of CGD with a Topics: Animals; Apoptosis; Biological Availability; Curcumin; Disease Models, Animal; Drug Delivery Systems; Endoplasmic Reticulum; Granulomatous Disease, Chronic; Humans; Leukocytes; Mice; Mice, Inbred C57BL; Mice, Knockout; Mutation; NADPH Oxidase 2; Nanoparticles; Polylactic Acid-Polyglycolic Acid Copolymer; Sarcoplasmic Reticulum Calcium-Transporting ATPases	2019

Article

Year

Targeted Delivery of Curcumin Rescues Endoplasmic Reticulum-Retained Mutant NOX2 Protein and Avoids Leukocyte Apoptosis.

Journal of immunology (Baltimore, Md. : 1950), 2019, 06-15, Volume: 202, Issue:12

Chronic granulomatous disease (CGD) is a primary immunodeficiency disease caused by defects in the leukocyte NADP oxidase. We previously reported that sarcoplasmic/endoplasmic reticulum calcium pump (SERCA) inhibitors could be used to rescue mutant H338Y-gp91phox protein of a particular type of CGD with a

Topics: Animals; Apoptosis; Biological Availability; Curcumin; Disease Models, Animal; Drug Delivery Systems; Endoplasmic Reticulum; Granulomatous Disease, Chronic; Humans; Leukocytes; Mice; Mice, Inbred C57BL; Mice, Knockout; Mutation; NADPH Oxidase 2; Nanoparticles; Polylactic Acid-Polyglycolic Acid Copolymer; Sarcoplasmic Reticulum Calcium-Transporting ATPases

2019